Trump Reaches Deals with Nine More Pharmaceutical Companies to Slash Drug Prices
President Donald Trump has struck deals with nine more pharmaceutical companies to slash drug prices for patients.
Trump announced the deals with Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB on Monday in the Oval Office while flanked by pharmaceutical executives.
.@POTUS announces a major expansion of his Most Favored Nation drug pricing initiative — with nine new pharmaceutical companies committing to deliver their lowest drug prices for American patients. pic.twitter.com/hNoPACjnVk
— Rapid Response 47 (@RapidResponse47) August 31, 2026
“I’m thrilled to announce a major expansion of one of our signature affordability initiatives, something that people have been trying to get for years, for decades, and I’m not even sure that other presidents tried,” Trump said of his most favored nation (MFN) drug pricing initiative.
“Nine new pharmaceutical companies are committing to deliver their lowest drug prices for American patients,” he added.
The agreements ensure that every state Medicaid program will have access to MFN drug prices for all nine companies’ products, which the White House projects will save Americans across the country billions of dollars. (Read more from “Trump Reaches Deals with Nine More Pharmaceutical Companies to Slash Drug Prices” HERE)
